New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Phreesia, Inc.
PHR
Shape
US Flag

NYSE

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Medical - Healthcare Information Services

Next Earning date - 03 Dec 2024

1B

Medical - Healthcare Information Services

Next Earning date - 03 Dec 2024

19.80USD
Shape-0.60 ( -2.94%)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

51%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

32%

Quote Panel

Shape
Updated October 19, 2024
1W -5.85 % 1M -16.07 % 3M -16.14 % 1Y 31.13 %

Key Metrics

Shape
  • Market Cap

    1.14B


  • Shares Outstanding

    57.77M


  • Share in Float

    53.97M


  • Dividende

    0


  • Earning Date

    03 Dec 2024


  • Price Target

    19.8


  • Average Volume

    352381


  • Beta

    0.932


  • Range

    12.05-29.155


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.phreesia.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.93x

P/S Ratio

4.53x

P/B Ratio

0.0

Debt/Equity

-25.7%

Net Margin

$-1.8

EPS

How PHR compares to sector?

P/E Ratio

Relative Strength

Shape

PHR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$419M

Shape310%

2025-Revenue

$1.22

Shape-293%

2025-EPS

$111M

Shape-1042%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Citigroup

upgrade

Previous: Not converted

2022-12-13

Now: Buy

SVB Leerink

upgrade

Previous: Not converted

2022-12-09

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.76
vs -0.71

Q1.23

arrow
arrow

N/A

-0.72
vs -0.90

Q2.23

arrow
arrow

N/A

-0.70
vs -0.99

Q3.23

arrow
arrow

N/A

-0.68
vs -0.89

Q4.23

arrow
arrow

N/A

-0.58
vs -0.76

Q1.24

arrow
arrow

N/A

-0.56
vs -0.72

Q2.24

arrow
arrow

N/A

-0.35
vs -0.70

Q3.24

arrow
arrow

N/A

-0.31
vs -0.68

Q4.24

arrow
arrow

N/A

-0.27
vs -0.58

Q1.25

arrow
arrow

N/A

-0.25
vs -0.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+31%

73.1M  vs 55.9M

Q1.23

arrow
arrow

+32%

76.6M  vs 58M

Q2.23

arrow
arrow

+32%

83.8M  vs 63.4M

Q3.23

arrow
arrow

+26%

85.8M  vs 67.9M

Q4.23

arrow
arrow

+25%

91.6M  vs 73.1M

Q1.24

arrow
arrow

+24%

95M  vs 76.6M

Q2.24

arrow
arrow

+21%

101.2M  vs 83.8M

Q3.24

arrow
arrow

+19%

102.1M  vs 85.8M

Q4.24

arrow
arrow

+16%

106.2M  vs 91.6M

Q1.25

arrow
arrow

+15%

109.5M  vs 95M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-13%

-0.13
vs -0.13

Q1.23

arrow
arrow

-13%

-0.13
vs -0.13

Q2.23

arrow
arrow

-14%

-0.14
vs -0.13

Q3.23

arrow
arrow

-15%

-0.15
vs -0.14

Q4.23

arrow
arrow

-12%

-0.12
vs -0.15

Q1.24

arrow
arrow

-12%

-0.12
vs -0.12

Q2.24

arrow
arrow

-8%

-0.08
vs -0.12

Q3.24

arrow
arrow

-7%

-0.07
vs -0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

183

183
vs 167

10%

Q4.22

arrow
arrow

182

182
vs 183

-1%

Q1.23

arrow
arrow

211

211
vs 182

16%

Q2.23

arrow
arrow

200

200
vs 211

-5%

Q3.23

arrow
arrow

183

183
vs 200

-8%

Q4.23

arrow
arrow

201

201
vs 183

10%

Q1.24

arrow
arrow

205

205
vs 201

2%

Q2.24

arrow
arrow

185

185
vs 205

-10%

Earnings Growth

Latest News